Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharmaceutical source : Www.biospace.com save search
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
companies biopharma platform
Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Published: 2024-04-17 (Crawled : 11:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
reminyl pharma acquisition
J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
sales revenue stelara
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
PRGO | $30.04 0.27% 0.0% 780K
|
Health Technology
|
| O: -0.22%
H: 0.8%
C: 0.06%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
ABT | News | $105.9 -3.03% 0.07% 12M
|
Health Technology
|
| O: -0.37%
H: 1.42%
C: 1.37%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
fda for
Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda
Published: 2024-04-04 (Crawled : 12:00) - biospace.com/
RMTI | $1.48 -0.67% -0.68% 160K
|
Health Technology
|
| O: 1.23%
H: 6.71%
C: 3.05%
distribution global medical
Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer
Published: 2024-04-04 (Crawled : 12:00) - biospace.com/
MRK | $125.37 0.25% 0.1% 6.1M
|
Health Technology
|
| O: 0.24%
H: 0.08%
C: -2.42%
mk-1084 keytruda lung merck cancer cell treatment trial
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $30.04 0.27% 0.0% 780K
|
Health Technology
|
| O: -0.29%
H: 1.34%
C: -0.64%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $105.9 -3.03% 0.07% 12M
|
Health Technology
|
| O: 0.11%
H: 0.37%
C: -0.77%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
fda drug schizophrenia
KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 12:00) - biospace.com/
KALV | $11.67 -1.77% -1.8% 300K
|
Health Technology
|
| O: -0.27%
H: 3.0%
C: 2.27%
conference pharmaceuticals
AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $30.04 0.27% 0.0% 780K
|
Health Technology
|
| O: -1.09%
H: 0.13%
C: -1.39%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
ABT | News | $105.9 -3.03% 0.07% 12M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
approval astrazeneca
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 02, 2024
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
KALV | $11.67 -1.77% -1.8% 300K
|
Health Technology
|
| O: -2.11%
H: 2.96%
C: -0.99%
nasdaq pharmaceuticals grants
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
EYPT | $20.94 -4.12% -4.3% 510K
|
Health Technology
|
| O: -3.01%
H: 4.27%
C: 3.15%
retina pharmaceuticals
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
NXTC | $1.51 -7.93% -8.61% 120K
|
Health Technology
|
| O: 2.83%
H: 17.89%
C: 14.22%
conference
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
CARA | $0.7475 5.43% 5.15% 180K
|
Health Technology
|
| O: 0.03%
H: 2.62%
C: 1.57%
conference therapeutics
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
CLSD | $1.255 9.13% 8.37% 320K
|
Health Technology
|
| O: 4.61%
H: 2.44%
C: -11.95%
conference
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
TCRX | News 0 d | $6.76 -5.19% -5.47% 1.6M
|
Professional, Scientific, and T...
|
| O: -1.3%
H: 0.0%
C: -9.89%
conference presentation therapeutics
Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25
Published: 2024-04-01 (Crawled : 12:00) - biospace.com/
MRK | $125.37 0.25% 0.1% 6.1M
|
Health Technology
|
| O: -0.23%
H: 0.19%
C: -0.52%
sales conference merck
Avalo Snags Former Eli Lilly Asset and $185M in Major Pipeline Pivot
Published: 2024-03-29 (Crawled : 15:30) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
| Email alert
Add to watchlist
pipeline
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-28 (Crawled : 11:00) - biospace.com/
KOD | $3.6 -7.46% -8.06% 610K
|
Health Technology
|
| O: -8.59%
H: 1.04%
C: -22.76%
business year sciences financial results
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer at High Risk of Recurrence in Adults
Published: 2024-03-28 (Crawled : 11:00) - biospace.com/
MRK | $125.37 0.25% 0.1% 6.1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
keytruda lung cancer cell risk plus
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
ANIP S | $65.5 -0.09% -0.09% 120K
|
Health Technology
|
| O: 0.43%
H: 0.66%
C: -0.23%
pharmaceuticals
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.